Tag - PRVCF

Executive Moves

Dr. Raj S. Pruthi joins PreveCeutical’s BOD

PreveCeutical Medical (CSE: PREV; OTCQB: PRVCF; FSE: 18H0) has appointed Raj S. Pruthi, MD, MHA, FACS, to its board of directors (BOD). Dr. Pruthi currently serves as CMO of Relmada Therapeutics. An accomplished...

March 30, 2026

Developments

PreveCeutical files patent for delivery of CNS-active agents

PreveCeutical Medical (CSE: PREV; OTCQB: PRVCF) has filed an international patent application for the delivery of CNS-active therapeutic agents covering methods and formulations aimed at addressing treatment challenges...

February 9, 2026

Tag - PRVCF

Dr. Raj S. Pruthi joins PreveCeutical’s BOD

PreveCeutical files patent for delivery of CNS-active agents

Subscribe